Skip to content

Glutamic Acid Decarboxylase (GAD65) Antibody, Serum/Plasma (Qualitative Line Blot)

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies against GAD65, a protein linked to autoimmune conditions affecting the pancreas. It helps diagnose or monitor type 1 diabetes or related autoimmune disorders.

Quick summary

["This test may help identify autoimmune conditions affecting the pancreas."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
81725-4
Short code
GAD65 Ab Ser Ql Line blot
Synonyms
GAD65 Ab Ser Ql Line blot
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why Is This Test Done?

Your healthcare provider may order this test if you have symptoms of type 1 diabetes, such as frequent urination, extreme thirst, unexplained weight loss, or fatigue. It may also be used in patients with unexplained pancreatic issues or other autoimmune conditions suspected to involve GAD65 antibodies.

What Does a Positive Result Mean?

A positive result suggests the presence of GAD65 antibodies, which can indicate an autoimmune response targeting pancreatic cells. This finding is often associated with type 1 diabetes or related autoimmune disorders, though it may not confirm the diagnosis alone.

What Does a Negative Result Mean?

A negative result means no detectable GAD65 antibodies were found in your sample. However, this does not rule out type 1 diabetes or other autoimmune conditions—other tests or follow-up may be needed.

How Is This Test Performed?

A blood sample is drawn from a vein in your arm. The sample is then tested using a line blot assay to detect GAD65 antibodies. This method detects the presence or absence of antibodies without providing a specific quantity.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

GAD65 antibodies are strongly associated with type 1 diabetes and other autoimmune conditions affecting the pancreas, such as insulinoma or autoimmune pancreatitis. Their presence can support a diagnosis of these conditions, but additional testing (e.g., glucose monitoring, C-peptide levels) may be required for confirmation. Early detection can help manage symptoms and prevent complications.

Short name

GAD65 Antibody Screening

Frequently asked questions

How long does it take to get results from this test?
Results from this qualitative test are typically available within 24 to 72 hours, depending on lab processing times. Follow-up with your healthcare provider to discuss the meaning of your results.
Can I eat or drink before this test?
No special preparation is needed for this blood test. However, avoid alcohol for 24 hours before your appointment, as it may affect antibody detection.
Is this test painful?
The blood draw may cause mild discomfort for a few seconds, but it usually resolves quickly. Most people tolerate the procedure well. If you have a fear of needles, let your healthcare provider know.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy